Should You Buy SpaceandPeople Plc, Integrated Diagnostics Holdings PLC And African Potash Ltd After Today’s Results?

Do SpaceandPeople Plc (LON: SAL), Integrated Diagnostics Holdings PLC (LON: IDHC) and African Potash Ltd (LON: AFPO) show great potential?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Cautious optimism

What’s SpaceandPeople (LSE: SAL) all about then? It does promotional space at more than 750 shopping centres, city centres, retail parks and the like — offering things like promotional kiosks and other marketing services. And it’s just released full year results for 2015.

With the termination of one of the firm’s agreements, UK operations fell back a little as expected, and gross revenue dropped from £31.6m in 2014 to £26.5m. But pre-tax profit before exceptionals stayed approximately the same at £1m, and with no non-recurring costs the company reported a basic EPS rise of 82% to 4.26p. The dividend  was lifted 10% to 2.2p per share, to yield 3.5%, and there was net cash of £0.7m on the books.

The shares have been up and down a little all morning, and at the time of writing I’m seeing a 2.5% rise to 61.5p, so what are the prospects for the future? Well, there’s a 54% rise in EPS forecast for the current year, with the dividend expected to grow to yield 4.3%. And that puts the shares on a forward P/E of just 10.

Chairman Charles G Hammond told us “We believe that SpaceandPeople is creating a solid platform for growth and a sustainable future“, and though it’s a very small company with a market cap of only £11.65m and comes with the commensurate risk, I’d be cautiously optimistic.

Egyptian healthcare bargain?

Integrated Diagnostics Holdings (LSE: IDHC) is an altogether bigger company, with a market cap of close to £500m, though that’s a little down from its value at flotation in May 2015. Priced in US dollars, the shares dropped as low as $3.85 in February this year, but since then we’ve seen a 34% recovery to today’s $5.15 — with  no change so far on the day full year results were released.

The Jersey-registered company bills itself as “Egypt’s largest fully integrated private-sector provider of medical diagnostics services“, and saw revenues grow 18% to 1,015 Egyptian Pounds (approximately £80m), with adjusted net profit up 18.4% and earnings per share up 9% — and the firm declared a dividend of six US cents per share for a modest yield of 1.2%.

Should you buy? Well, the combination of an AIM listing, an overseas registration, and operating in Egypt will add risk for sure. But that’s offset by forecasts of 47% EPS growth this year and 25% next, which would drop the P/E to 13 by the end of 2017 — and dividends are predicted to yield 3.7% by then.

Potash potential

Potash is in the news of late with Sirius Minerals‘ York Potash project looking increasingly promising, and today we have interim results from African Potash (LSE: AFPO). It’s another tiddler, with a market cap of £14m, and is registered in Guernsey this time. As I write, the shares are down 14% to just 1.45p, but that still represents a quadrupling over the past 12 months — so how did the results go?

The company realised its first revenue from the fertilizer trade in December, of $59,000, and has a trading agreement in place with the Common Market for Eastern and Southern Africa. But there’s obviously some way to go yet before they see any profit, with a pre-tax loss of $716,000 reported, together with a cash balance as of 31 December of $509,000.

I think it’s fairly obvious that means a fair bit more cash (and the corresponding dilution) will be needed in the coming few years to fund the company’s development — and in January this year we’ve already seen a $1.18m share placing. There’s potential here, but it’s too risky for me.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

It’s up 70%, but the experts expect the IAG share price to climb still further

Why didn't I buy when I was convinced the IAG share price was likely to soar? And is there still…

Read more »

Businessman use electronic pen writing rising colorful graph from 2023 to 2024 year of business planning and stock investment growth concept.
Investing Articles

2 UK stocks with recovering profit margins

This writer considers a pair of UK stocks with very different share price trajectories following the pandemic. Would he buy…

Read more »

The flag of the United States of America flying in front of the Capitol building
Investing Articles

Will Trump’s tariffs squeeze this FTSE 100 giant’s profits?

Our writer looks at how the latest news around US tariffs might impact FTSE 100 company Diageo. Should he be…

Read more »

Investing Articles

Up 95%, is this FTSE winner the best high-yield star for me to buy now?

Do we have to choose between share price growth and high-yield dividends? In this case, over the past year, it…

Read more »

Asian Indian male white collar worker on wheelchair having video conference with his business partners
Investing Articles

2 dividend-paying FTSE shares that could benefit from the AI revolution

Our writer examines two dividend-paying FTSE shares and explains some of the opportunities and risks he sees in their exposure…

Read more »

Investing Articles

Up 140% and rocketing out of the FTSE 250! Is it too late for me to buy this red-hot stock?

Miniature war games hero Games Workshop has outgrown the FTSE 250 and is hammering at the door of the UK's…

Read more »

Investing Articles

If I invest £10,000 in Taylor Wimpey shares, how much passive income will I receive?

Taylor Wimpey shares have fallen and are now paying a huge dividend. How much might I receive by investing a…

Read more »

Index Funds text carved in stone background
Investing Articles

Why I choose to invest in individual stocks rather than an index fund

Our writer examines the differences between stock picking and investing in index funds and why he feels there’s more to…

Read more »